Season’s Greetings from the Equilibar Team! -

Season’s Greetings from the Equilibar Team!

As always, we are thankful for our customers and partners around the world, and we wish everyone peaceful and meaningful holidays. Equilibar offices will be closed December 25, 2023, through January 1, 2024, to allow our hard-working team members to rest and celebrate with their friends and family.

We feel fortunate to have had the opportunity to work on many impactful projects in 2023. Our news blog gives a glimpse of some of these exciting collaborations—if you are looking for technically focused reading material during the holidays, we invite you to browse!

Here are a few to consider:

Hydrogen Energy Cycle : Within the last few years, we’ve seen tremendous interest from multiple segments of the hydrogen fuel industry due to our devices’ ability to provide stable pressure control across a wide flow rate range as well as their ease of automation and simple design.

Single Use for New Pharmaceutical Applications : As flow chemistry is adopted by the pharmaceutical industry, the demand for single use fluid control grows. An exciting case study focuses on using dome-loaded multiple orifice fluid control to meet multiple demands.

Process Control for Cultivated Meat : Sustainability and ethical concerns are driving the exploration of alternative proteins. Agile and reliable process controls are key to scaling up these burgeoning fields.

Advanced Flow Control for Multiple Markets : A new video gives an inside view of our flow control devices to demonstrate the advantages of direct sealing diaphragm technology for a wide array of complex flow control applications including carbon capture, biopharmaceuticals and electronics.

Semiconductor fabrication : While digital technology has evolved at a brisk pace for decades, multiple factors are in play to make the coming year especially significant for the semiconductor and microchip industries. Precise pressure and vacuum control are key to these types of applications.

With a new year on the horizon, we look forward to even more exciting projects and hope you will feel free to contact our experienced engineers about your particular fluid control scenario. They enjoy hearing about new challenges.

Happy Holidays to all!

 

Categories
Equilibar News
PUK magazine cover with stainless steel device

Journal article focuses on oligonucleotide production using pressure control with built in dampener

Oligonucleotide drugs are made up of short sections of genetic sequences and are used to target disorders in the genetic code. The first drug of this type was used in 1998 during the AIDS epidemic.  Since then, the field has accelerated rapidly and today many oligonucleotide drugs are in clinical trials, promising improvements in treatment Read More

Read More